Home » Stocks » MASI

Masimo Corporation (MASI)

Stock Price: $219.12 USD 4.19 (1.95%)
Updated May 13, 2021 4:00 PM EDT - Market closed
After-hours: $220.41 +1.29 (0.59%) May 13, 5:20 PM
Market Cap 11.82B
Revenue (ttm) 1.17B
Net Income (ttm) 229.23M
Shares Out 55.20M
EPS (ttm) 3.94
PE Ratio 55.60
Forward PE 59.88
Dividend n/a
Dividend Yield n/a
Trading Day May 13
Last Price $219.12
Previous Close $214.93
Change ($) 4.19
Change (%) 1.95%
Day's Open 217.22
Day's Range 214.75 - 220.27
Day's Volume 350,713
52-Week Range 203.81 - 284.86

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new study found that Masimo O3® Regional Oximetry may aid in monitoring septic shock patients and may have value as a predictor of mortality.

3 days ago - Business Wire

Here are the stocks seeing the most insider buying this week

YouTube video

Brian Sullivan's weekly segment on Worldwide Exchange brings you the top five stocks seeing the most insider buying action this week.

Other stocks mentioned: APH, ASB, LLY, ROK
6 days ago - CNBC Television

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo announced the findings of the first study to evaluate the utility of PVi® on patients treated with nasal high-flow therapy.

1 week ago - Business Wire

Masimo (MASI) continues to gain from its key Product segment, which makes a solid progress in Q1.

2 weeks ago - Zacks Investment Research

Masimo (MASI) delivered earnings and revenue surprises of 2.27% and 0.30%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 weeks ago - Zacks Investment Research

Shares of Masimo (NASDAQ:MASI) remain flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 7.22% year over year to $0.90, which beat the est...

2 weeks ago - Benzinga

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (Nasdaq: MASI) today announced its financial results for the first quarter of 2021, ended April 3, 2021. First Quarter 2021 Results: Product revenue increased 10....

2 weeks ago - Business Wire

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) has changed the date for the release of its first quarter 2021 financial results to Monday, April 26, 2021 due to executive scheduling changes. The...

3 weeks ago - Business Wire

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release first quarter 2021 financial results for the period ended April 3, 2021, after the market closes on Tuesday, April 27, 2021. The confe...

4 weeks ago - Business Wire

Investor optimism is high on Masimo (MASI) stock, courtesy of its solid prospects.

4 weeks ago - Zacks Investment Research

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Radius PCG™, a portable mainstream capnograph that connects wirelessly to the Root® Patient Monitoring Hub, has received FDA clearance.

1 month ago - Business Wire

Cantel (CMD), Hill-Rom (HRC), LeMaitre (LMAT) and Masimo (MASI) can prove to be prudent investment choices in the critical care industry of the MedTech sector.

Other stocks mentioned: CMD, HRC, LMAT, RMD
1 month ago - Zacks Investment Research

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the 20th Annual Needham Healthcare Conference on Monday, April 12, 2021 at 3:45 ...

1 month ago - Business Wire

NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new study investigating the impact of rescue therapies on the brains of patients with severe COVID-19 used Masimo O3® Regional Oximetry.

1 month ago - Business Wire

NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new study evaluated the accuracy of Masimo RRp® by comparing it to manual respiration rate counting on hospitalized, malnourished children.

1 month ago - Business Wire

Masimo (MASI) reported earnings 30 days ago. What's next for the stock?

1 month ago - Zacks Investment Research

The latest study highlights the efficacy of using Masimo's (MASI) SET pulse oximetry in screening CCHD in newborns.

1 month ago - Zacks Investment Research

NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new CCHD screening study with Masimo SET® pulse oximetry recommended the implementation of pulse oximetry screening for all newborns in Sri Lanka.

1 month ago - Business Wire

The latest study highlights the importance of Masimo's (MASI) EMMA for children with tracheostomy, both in home-care settings and outpatient departments.

1 month ago - Zacks Investment Research

NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new study found the Masimo EMMA® Capnograph useful in the assessment of respiratory condition in children with tracheostomy.

1 month ago - Business Wire

According to the All-in-One Screener, a Premium feature of GuruFocus, four companies that have high profitability, business predictability and free cash flow growth are Autohome Inc. (NYSE:ATHM), Masimo...

Other stocks mentioned: ATHM, MPWR, SNPS
2 months ago - GuruFocus

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo provides a variety of innovative monitoring solutions designed to improve maternal and newborn safety, including SET® pulse oximetry.

2 months ago - Business Wire

These four MedTech stocks -- ABT, JNJ, MDT and MASI -- are expected to gain enormously from FDA's SaMD Action Plan 2021.

Other stocks mentioned: ABT, JNJ, MDT
2 months ago - Zacks Investment Research

Masimo's (MASI) Rad-G with Temperature, which aids clinicians in seamless assessment of key vital signs through a single device, gets CE marking.

2 months ago - Zacks Investment Research

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo Rad-G™ with Temperature, a rugged handheld device with SET® pulse oximetry, respiration rate, and temperature measurement, received CE marking.

2 months ago - Business Wire

Masimo (MASI) continues to gain from its key Product segment, which witnessed solid growth in Q4.

2 months ago - Zacks Investment Research

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Raymond James 42nd Annual Institutional Investors Conference on Wednesday, M...

2 months ago - Business Wire

Shares of Masimo (NASDAQ:MASI) fell  in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 7.69% year over year to $0.98, which beat the estimate ...

2 months ago - Benzinga

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (Nasdaq: MASI) today announced its financial results for the fourth quarter and full-year ended January 2, 2021. Fourth Quarter 2020 Results: Total revenue for th...

2 months ago - Business Wire

IRVINE, Calif.--(BUSINESS WIRE)--Masimo softFlow®, innovative high-flow nasal cannula therapy, is now available in the U.S. for spontaneously breathing adult patients.

2 months ago - Business Wire

Masimo Corporation (MASI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

2 months ago - Zacks Investment Research

Rebound in sales volumes and rise in COVID-19 support products sales make us optimistic about MDT, MASI, XRAY and COO's results.

Other stocks mentioned: BSX, COO, HOLX, LH, MDT, XRAY
2 months ago - Zacks Investment Research

Masimo (MASI) SafetyNet-OPEN aids organizations in detecting those who are most vulnerable to COVID-19.

2 months ago - Zacks Investment Research

IRVINE, Calif.--(BUSINESS WIRE)--As previously announced on January 13, Masimo (NASDAQ: MASI) will release fourth quarter and full year 2020 financial results for the period ended January 2, 2021, after...

2 months ago - Business Wire

IRVINE, Calif.--(BUSINESS WIRE)--Masimo SafetyNet-OPEN™, a web and mobile app solution that helps organizations stay open safely during COVID-19 and beyond, has full market release.

2 months ago - Business Wire

Latest study favors Medtronic's (MDT) Nellcor Pulse Oximetry for all newborns considered for study, unlike from those newborns with Masimo's oximeter.

Other stocks mentioned: MDT
3 months ago - Zacks Investment Research

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the BTIG MedTech and Digital Health Conference on Thursday, February 18, 2021 at...

3 months ago - Business Wire

Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

3 months ago - Zacks Investment Research

IRVINE, Calif.--(BUSINESS WIRE)--Masimo has successfully completed the acquisition of LiDCO, a leading provider of advanced hemodynamic monitoring systems.

3 months ago - Business Wire

BMEZ delivered solid results throughout 2020, helped by the healthcare sector overall. This fund doesn't just invest in your typical healthcare companies though and tilts towards smaller and private inv...

Other stocks mentioned: ANNX, ASA, BME, BMEZ, BST, BSTZ, GMAB ...
3 months ago - Seeking Alpha

Masimo's (MASI) iSirona helps in efficient workflow in hospitals by providing continuous connectivity, thereby helping clinicians to improve patient outcomes.

3 months ago - Zacks Investment Research

IRVINE, Calif.--(BUSINESS WIRE)--Masimo announced iSirona™, a compact, versatile, connectivity hub that routes data from medical devices to the Masimo Hospital Automation™ platform.

3 months ago - Business Wire

Per the preliminary announcement, Masimo (MASI) projects 2020 product revenues to improve.

3 months ago - Zacks Investment Research

The booming digital health space has been witnessing significant M&A activities amid the pandemic.

Other stocks mentioned: AMN, PHG, RCM
3 months ago - Zacks Investment Research

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial and operational results for the full-year ended January 2, 2021 and provided estimates for...

4 months ago - Business Wire

Masimo (MASI) is lending support to Renown Health through Masimo SafetyNet in order to manage the COVID-19 surge.

4 months ago - Zacks Investment Research

IRVINE, Calif.--(BUSINESS WIRE)--Masimo is helping Renown Health address the COVID-19 surge, in part through use of Masimo SafetyNet™, a remote patient management solution.

4 months ago - Business Wire

Researchers on probe discover that the use of Masimo's (MASI) SpHb was related to the lower rate of postoperative transfusion, minimal duration of ICU stay and other better outcomes.

4 months ago - Zacks Investment Research

NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new study used Masimo ORi™, Oxygen Reserve Index, to help limit the extent of postoperative hyperoxia.

4 months ago - Business Wire

NEUCHATEL, Switzerland--(BUSINESS WIRE)--In a study of pediatric patients, Masimo SpHb® was associated with improved outcomes, including reduced postoperative transfusion and ICU stays.

5 months ago - Business Wire

About MASI

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion ind... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Aug 8, 2007
CEO
Joseph Kiani
Employees
2,000
Stock Exchange
NASDAQ
Ticker Symbol
MASI
Full Company Profile

Financial Performance

In 2020, Masimo's revenue was $1.14 billion, an increase of 21.96% compared to the previous year's $937.84 million. Earnings were $240.30 million, an increase of 22.47%.

Financial Statements

Analyst Forecasts

According to 9 analysts, the average rating for Masimo stock is "Buy." The 12-month stock price forecast is 295.67, which is an increase of 34.94% from the latest price.

Price Target
$295.67
(34.94% upside)
Analyst Consensus: Buy